Extracellular ATP modulates cardiac contraction through P2-purinoceptors on cardiac myocytes. To elucidate the molecular mechanism of this response, we examined the effects of P2-purinoceptor activation on phosphoinositide (PI) hydrolysis and the cAMP system in cultured ventricular myocytes of fetal mice. In a concentration-dependent manner, ATP stimulated accumulations of [3H]inositol monophosphate, bisphosphate, and trisphosphate with the half-maximum effective concentration of -1 ,uM in the myocytes labeled with [3H] inositol. The order of efficacy of a series of adenyl compounds for stimulation of PI hydrolysis was adenosine 5'-0-(3-thiotriphosphate) (ATPyS), ATP>ADP, 5'-adenylylimidodiphosphate (APPNP) >c4,-methyleneadenosine 5'-triphosphate (APCPP) >f3,,-methyleneadenosine 5'-triphosphate, AMP>adenosine. On the other hand, 100 f&M ATPyS inhibited isoproterenol-induced accumulation of cAMP by -70%o without decreasing the time to maximal cAMP levels, as measured by radioimmunoassay. This response was also concentration dependent, with a half-maximum inhibitory concentration (IC50) of -1 liM. All of the tested ATP, ADP, and ATP analogues inhibited the cAMP system, and the responses to ATPyS, APPNP, and APCPP were insensitive to an A1-purinoceptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine. Pertussis toxin attenuated the ATP-induced PI hydrolysis by no more than 25% at 100 ng/ml but completely suppressed the ATP'yS-induced inhibition of the cAMP system. Protein kinase C-activating phorbol ester, 4f3-phorbol 123-myristate 13a-acetate, inhibited the ATP-induced PI hydrolysis with an IC50 of -1 nM and also attenuated the ATPyS-induced inhibition of the cAMP system at 21 nM, although a biologically inactive phorbol ester, 4a-phorbol 12,13-didecanoate, did not. From these data, P2-purinoceptor activation stimulates PI hydrolysis by activating phospholipase C primarily through pertussis toxin-insensitive G proteins and attenuates cAMP accumulation by inhibiting adenylate cyclase through pertussis toxin-sensitive G proteins. Protein kinase C is likely to negatively regulate both the signal transduction systems.
n 1929, Drury and Szent-Gyorgyi,l for the first time, reported that adenylic acid and adenosine produced sinus bradycardia, complete atrioventricular block, a negative inotropic effect on the atrium, and cessation of atrial fibrillation in the mammalian heart. In 1934, Gillespie2 described that ATP increased the strength of beat in the frog heart. From these and other observations, Drury3 suggested, in 1936, that ATP and adenosine might have different effects on cardiac contraction. Since then, a large body of evidence of the effects of adenyl compounds on cardiac contraction had been accumulated, but the mode of the action was obscure until, in 1977, Schrader 3) positive and negative inotropic effects on the amphibian atrium, 14 4 ) a negative inotropic effect on the mammalian atrium,14,15 and 5) positive16'17 and negative15"17 inotropic effects on both the mammalian and amphibian ventricles. Among these, at least, the positive inotropic effect is likely to be mediated by P2-purinoceptors, because A1-purinoceptor agonists, which are formed from ATP degradation,18 do not have such an effect.7 In contrast, the others have been usually ascribed to A,-purinoceptor activation.10'13-15 However, it is still uncertain whether they are evoked entirely through this type of receptor.7 For example, ATP has been reported to induce a negative inotropic effect through P,-purinoceptors in the rat ventricle15 and to stimulate an inwardly rectifying K' current in the bullfrog atrium in which adenosine had no effects.19
Thus, P2-purinoceptor-mediated responses seem to be considerably different among species and anatomic portions in the heart, and some of them appear to be contradictory to others. This fact strongly suggests that there is more than one kind of molecular mechanism by which P2-purinoceptors regulate cardiac contraction. If so, precise characterization of the intracellular signal transduction systems linked with the receptors in cardiac myocytes is presumably necessary to understand these complex physiological responses. This is especially true, because our understanding of the molecular mechanisms of regulation of cardiac contraction by extracellular signals has been making a marked progress in recent years.
Based on this aspect, we focused our present investigation on the effects of P2-purinoceptor activation on two major intracellular signal transduction systems in the cardiac myocyte, phosphoinositide (PI) hydrolysis and the cAMP system. This study suggests that P2-purinoceptor activation stimulates PI hydrolysis by activating phospholipase C (PLC) primarily through PTX-insensitive G proteins and inhibits the cAMP system by inhibiting AC through PTX-sensitive G proteins in cardiac myocytes and that protein kinase C (PKC) is likely to negatively regulate both the signal transduction systems. Our preliminary data were described elsewhere.20
Materials and Methods Cell Culture
Single-cell cultures were prepared as previously described.21 In brief, the ventricles obtained from 14-dayold fetal mice of the ddY strain were minced in phosphate-buffered saline (PBS) with Ca2' and Mg2+ (PBS+) and digested with trypsin in PBS without Ca2+ and Mg2+ (PBS-) at 37°C. The dissociated cells were collected into ice-cold Eagle's minimum essential medium (MEM) with 10% fetal calf serum and were preplated in the same medium at 37°C for 1 hour to reduce the number of contaminated nonmyocardial mesenchymal cells (nonmyocytes). The myocytes left in the suspension were collected and plated into 35-mm dishes (5 x105 cells per dish). After incubation at 37°C for 15 hours, the cells were washed with PBS+ to remove nonattached cells.
Assay Conditions for PI Hydrolysis and Separation of [3H]Inositol Phosphates
The cultured myocytes were treated at 37°C with serum, 20 ,uCi/ml per dish of myo-[2-'H]inositol, and if necessary, PTX as previously described.21 After 24 hours, the myocytes were washed with MEM with 0.1% bovine serum albumin and incubated at 37°C for another 5 hours in the same fetal calf serum-free medium with or without PTX. At the end of this procedure, myocytes were up to 90% of the cultured cells. PTX (up to 1 ug/ml) did not significantly affect incorporation of ['H]inositol into PIs nor basal inositol phosphate levels. Subsequently, they were washed once more with MEM containing 0.1% bovine serum albumin and 20 mM HEPES-buffered MEM at pH 7.4 and were preincubated in 0.9 ml of the same medium supplemented with 20 mM LiCl at 37°C for 15 minutes. When indicated, the myocytes were treated with various antagonists or phorbol esters in this period. Phorbol ester, 4,B-phorbol 12,3-myristate 13ca-acetate (PMA), did not significantly change basal inositol phosphate levels at 100 nM, and its vehicle dimethylsulfoxide (DMSO) did not affect either basal or ATP-induced PI hydrolysis at 0.01%. Adenosine deaminase (ADA) and a phosphodiesterase inhibitor, 4-(3-butoxy-4-methyoxybenzyl)-2-imidazolidone (Ro 20-1724), were added to the assay medium as in the assay for the cAMP system (see below); the results did not change. Then, the myocytes were stimulated for 5 minutes by adding 0.1 ml ATP or various adenyl compounds. The reactions were stopped with ice-cold trichloroacetic acid. The acid extracts containing [3HJinositol phosphates were transferred to test tubes, and the acid was removed with diethyl ether. The final extracts were neutralized with NaOH applied to columns containing Dowex AG lx 8 formate-form resins (Bio-Rad Laboratories, Richmond, Calif.) and eluted to separate inositol phosphates by the method described previously. 21 In this study, contribution of nonmyocytes to observed PI hydrolysis was estimated at <6% (data not shown) and neglected.
Assay Conditions for the cAMP System
Until the end of the serum deprivation, the myocytes were treated essentially in the same way as in the assay for PI hydrolysis, except that ['H]inositol was omitted. Urea (up to 2 mM), a vehicle of PTX, used in this period did not significantly affect cAMP accumulation. Thereafter, the myocytes were quickly washed once at 37°C with 0.9 ml HEPES-buffered MEM and preincubated in 0.9 ml of the same medium supplemented with 0.5 mM Ro 20-1724 and 0.5 units/ml ADA on a tray in a water bath at 37°C for 15 minutes. If necessary, the HEPES-buffered medium was further supplemented with antagonists or phorbol esters. DMSO, the vehicle of phorbol esters and 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), did not significantly affect cAMP accumulation at 0.01%. LiCI, if added as in the assay for PI hydrolysis, did not change results. Subsequently, the myocytes were stimulated for 5 minutes by adding 0.1 ml various agents. If an adenyl compound was used with isoproterenol, they were always added simultaneously. In this assay, a less hydrolyzable ATP analogue, adenosine 5'-0-(3-thiotriphosphate) (ATPyS), was routinely used as a P2-purinoceptor agonist instead of ATP, because ATPyS selectively stimulated P2-purinoceptors, but ATP did not ( Figure 3B ). The reactions were inositol-free MEM containing 3% dialyzed fetal calf stopped by rapidly aspirating the medium and adding 1 ml ice-cold 0.1N HCl. The myocytes were chilled on ice for 1 hour to extract cAMP, and the acid extracts were collected in test tubes. The myocytes were washed once with 1 ml of 0.1N HCl, and the washing was combined with the original extracts. The amount of cAMP released from the myocytes into the assay medium was <2% of the total synthesized cAMP and was negligible (data not shown). The extracts were submitted for measurement of cAMP content by radioimmunoassay as previously described.22 Contribution of contaminated nonmyocytes to observed cAMP accumulation was <3% (data not shown) and was neglected. Reagents for radioimmunoassay of cAMP were obtained from a Yamasa cAMP assay kit from Yamasa Shoyu Co., Chiba, Japan. Other materials and chemicals were obtained from commercial sources as previously described. 21 Adenine nucleotides were dissolved in distilled water on the day of assay and stored on ice until used. When they were used, the same concentration of MgC12 as that of nucleotides was added to the assay medium. A solution of 10 mM 8-PT was made up in 80% (vol/vol) methanol containing 0.2 M NaOH on the day of assay, and aqueous dilutions of this were used.24 R-PIA and Ro 20-1724 were stored at 4°C as 100-mM solutions in 100% DMSO. DPCPX was dissolved in DMSO and diluted to 100 nM in HEPES-buffered MEM to avoid surface absorption25 on the day of assay and stored on ice until used. ADA was previously dialyzed against 106 vol PBSat 40C,26 diluted to 0.5 units/ml with HEPESbuffered MEM on the day of assay, and stored on ice until used. Other chemicals were prepared and used as described previously.2' Determinations Radioactivity of [3HI-labeled samples was determined by a liquid scintillation counter (model LS3801, Beckman Instruments, Inc., Fullerton, Calif.). Scintillant consists of 2 vol toluene/2,5-diphenyloxazole (final concentration, 4 g/l) combined with 1 vol polyoxyethylene (10) octylphenyl ether. The counting efficiency of this system assessed by the internal standard method was 28.4±+ 0.4% (mean+SEM, n = 18). Radioactivity of [l"I]-labeled samples was determined by a gamma counter (model 1261, Multi Gamma, Pharmacia, Turku, Finland).
Statistical Analysis
All values are expressed as mean+SEM. Differences between treatments and/or three inositol phosphates were assessed using two-way analysis of variance, followed by the Bonferroni method for multiple compari- son between pairs.27 A value of p<0.05 was considered statistically significant.
Results

P2-Purinoceptor-Mediated PI Hydrolysis
As shown in Figure 1 , when cultured myocytes were treated with 100 ,uM ATP, inositol monophosphate (IP,) increased almost linearly about threefold for 15 minutes in the presence of a myo-inositol 1-phosphatase inhibitor LiCI.28 Thus, ATP would stimulate PI hydrolysis by activating PLC. Inositol bisphosphate (IP2) and inositol trisphosphate (IP3) rapidly increased about sevenfold and fourfold for the initial 5 minutes, respectively, and gradually decreased. On the other hand, MgCl2 (100 ttM) did not significantly stimulate PI hydrolysis. ATP evoked these responses concentrationdependently with the half-maximum effective concentration of -1 ,uM ( Figure 2 ). Figure 3A shows the net accumulation of total inositol phosphates induced by various adenyl compounds at their maximal effective concentration of 100 ,M. ATP and ADP stimulated PI hydrolysis much more effectively than did adenosine or AMP. Their potency order was also ATP, ADP>AMP, adenosine (data not shown). In addition, neither P1-purinoceptor antagonist 8-PT, a1-adrenergic antagonist prazosin, muscarinic cholinergic antagonist atropine, nor S2-serotonergic antagonist ketanserin significantly antagonized ATP-induced PI hydrolysis (Table 1). These data indicate that ATP stimulates PI hydrolysis through P2-purinoceptors.5
The order of efficacy of ATP, ADP, and a series of ATP analogues was ATPyS, ATP>ADP, APPNP>APCPP> APPCP ( Figure 3A ), and their potency order was the same (data not shown).
P2-Purinoceptor-Mediated Inhibition of the cAMP System
We next examined the effect of P2-purinoceptor activation on the cAMP system. ATPyS decreased isoproterenol-induced cAMP accumulation by -70% without affecting a basal cAMP level ( hydrolysis in the myocyteS,21 had no significant effects on the cAMP system. Thus, this response to ATPy S was not evoked through the P2-purinoceptor-mediated PI hydrolysis. As in Figure 4 , cAMP rapidly increased within the initial 5 minutes and then leveled off in the presence of isoproterenol alone. ATPyS substantially inhibited the magnitude of this response without decreasing the time to maximal cAMP levels. In general, this time should be inversely related to the rate of cAMP degradation,29 and this inhibitory effect of ATPyS was significant as early as at 1 minute. Thus, ATP^yS is likely to attenuate cAMP accumulation by inhibiting AC. This response was evoked concentration-dependently with a half-maximum inhibitory concentration (IC5o) of -1 ,uM and was insensitive to the A1-antagonist DPCPX ( Figure 5 ). Because this antagonist suppressed the inhibition of the cAMP system by the Al-agonist R-PIA as reported ( Figure 5 and Table 3 ),23,25 ATPyS is most likely to inhibit the cAMP system through P2-purinoceptors. Muscarinic cholinergic receptors are reported to mediate some ATP-induced responses.7 However, atropine did not significantly antagonize the effect of ATPyS (Table 4 ). Other adenyl compounds also inhibited the cAMP system in varying degrees, although adenosine had no effects in the presence of ADA ( Figure 3B ). The responses to AMP and R-PIA were substantially antagonized by DPCPX, as expected.7 However, APPNP-and APCPP-induced responses were insensitive to it, indicat- ing that they are also mediated by P2-purinoceptors. Based on this aspect, the responses to ATP, ADP, and APPCP, which were sensitive to DPCPX, seem to be mediated by both P2and A1-purinoceptors. Actually, these compounds are known to be degraded to AMP and/or adenosine by ectoenzymes on cardiac myocytes.30,31
Effect of PTX on P2-Purinoceptor-Mediated PI Hydrolysis and Inhibition of cAMP Accumulation As depicted in Figure 6 , PTX did not significantly attenuate ATP-induced accumulation of IP1 at <10 ng/ml and of 1P2 and 1P3 at <100 ng/ml. Even at 100 ng/ml, PTX decreased these responses by no more than 25%. In contrast, PTX completely suppressed ATPySinduced inhibition of the cAMP system in a concentra- tion-dependent manner with an IC50 of -0.03 ng/ml (Figure 7) . PTX did not affect basal or isoproterenolinduced accumulation of cAMP in all concentrations used (Figure 7 and data not shown).
PKC-Induced Negative Feedback Regulation of
P2-Purinoceptor-Mediated PI Hydrolysis and
Inhibition of cAMPAccumulation PKC-activating phorbol ester PMA inhibited ATPinduced accumulations of IP1 and 1P2 by -70% and of 1P3 by -60% with an IC50 of --1 nM (Figure 8 ). Another PKC-activating phorbol ester, phorbol 12,13-dibutyrate, also exerted a similar response with an IC50 of -3 nM (data not shown). However, a biologically inactive phorbol ester, 4a-phorbol 12,13-didecanoate (4aPDD), had no significant effects at 1 1M (Figure 8 ). These data suggest that PKC negatively regulates P2-purinoceptormediated PI hydrolysis. 32 On the other hand, PMA increased cAMP accumulation in the presence of isoproterenol plus ATPyS but slightly decreased cAMP accumulation in the presence of isoproterenol plus R-PIA ( Figure 9A ). However, PMA also altered the isoproterenol-induced response. Thus, the results in the presence of isoproterenol plus ATPyS or R-PIA are expressed as a percentage of those in the presence of isoproterenol alone in Figure 9B . The interaction between concentrations of PMA and the presence of ATPyS or R-PIA was significant. In fact, PMA significantly attenuated the ATPyS-induced inhibition of the cAMP system at >1 nM but augmented the R-PIAinduced inhibition at 100 nM. Neither response was affected by 4aPDD (100 nM) ( Figure 9B ). From these data, PKC is likely to attenuate P2-purinoceptor-mediated inhibition of the cAMP system but might not affect, or rather augnent, inhibition through A,-purinoceptors.32
Discussion
Dual Second Messenger Cascades Coupled to P2-Purinoceptors in Cardiac Myocytes
These results indicate that the extracellular signals recognized at P2-purinoceptor sites are transmitted into cardiac myocytes through PI hydrolysis and the cAMP system. This is the first report that describes the dual signal transduction systems coupled to P2-purinoceptors in cardiac myocytes. P2-purinoceptor-mediated PI hydrolysis is consistent with the previous observation in the rat ventricular muscles.'6 Inhibition of the cAMP system by adenyl compounds in the heart, however, has been usually ascribed to A1-purinoceptor activation by themselves or by their degradation products,7 but P2purinoceptors are also likely to mediate this response (Figures 3B and 5 ). Similar dual signaling pathways coupled to the receptors are reported in different cell types as well. [33] [34] [35] [36] PI hydrolysis and the cAMP system often interact with each other: PI hydrolysis sometimes inhibits the cAMP system.37 However, this was not the case in the myocytes because of the following observations: 1) 5-HT stimulated PI hydrolysis but did not inhibit the cAMP system (Table 2) . 2) Neither PMA nor the calcium ionophore A23187 inhibited isoproterenol-induced cAMP accumulation ( Figure 9A and data not shown). 3) PTX completely abolished the inhibition of the cAMP system without completely suppressing the PI hydrolysis ( Figures 6 and 7) . On the other hand, accumulation of cAMP often attenuates PLC activity.37 If this were the case, P2-purinoceptor-mediated inhibition of the cAMP system would augment the PI hydrolysis through the same receptors. However, 1 mM dibutyryl cAMP did not significantly inhibit the PI hydrolysis (data not shown), and P2-purinoceptor activation stimulated PLC without reducing the basal cAMP level (Table 2) . Thus, P2-purinoceptors directly regulate both PLC and AC in cardiac myocytes, and these two second messenger cascades are independent of each other.
Subclassification of P2-Purinoceptors in Cardiac Myocytes
The receptors coupled to PI hydrolysis exhibit some of the characteristics of the P2Y-receptor: ATP was more potent than APCPP and APPCP (data not shown).'8
However, the most potent P2Y-receptor agonist, 2-meth-ylthioATP,'8 was less potent than ATP (data not shown). Thus, the receptors could not be fitted into either the P2X or P2Y type. 38 On the other hand, comparison of the relative potencies of various agonists in inhibiting the cAMP system was complicated by the fact that a competitive antagonist, DPCPX, did not completely eliminate A1-purinoceptor-mediated responses at 100 nM ( Figure 3B ). Nevertheless, there seems to be a similarity between the order of efficacy of various agonists for stimulation of PI hydrolysis and for inhibition of the cAMP system in the presence of DPCPX (Figure 3 ). Thus, both the signal transduction systems might be regulated by single P2-purinoceptors. This is consistent with the idea that P2-purinoceptors are likely to be the common site of PKC action in both the signal transduction systems (see below). However, further investigation would be required to fully classify the P2-purinoceptors.
G Proteins Coupled to P2-Purinoceptors in Cardiac Myocytes Figure 7 indicates that P2-purinoceptors couple to AC through PTX-sensitive G proteins. PLC is also believed to be regulated by G proteins.39 A direct G protein activator, fluoroaluminate, stimulated PI hydrolysis in the myocytes as well,21 and P2-purinoceptors have been actually reported to couple to PLC through G proteins.40 Some G proteins coupled to PLC are PTX sensitive, but the others are not. 39 In this study, a very high concentration of PTX partially inhibited P2-purinoceptor-mediated PI hydrolysis ( Figure 6 ), and 1 ,ug/ml PTX, which was sufficient to ADP-ribosylate all detectable PTX substrate in the myocytes,21 attenuated the response by -35% (data not shown). Because PTX (up to 1 ,ug/ml) did not reduce basal inositol phosphate levels nor incorporation of ['H]inositol into PIs, this phenomenon should be attributed to partial inhibition of P2-purinoceptor-PLC coupling. Similar observations are also reported in different cell types.3536 In the myocytes, PLC seems capable of coupling to both PTX-sensitive and -insensitive G proteins, because PTX partially inhibited fluoroaluminate-induced PLC activation on the one hand and because 5-HT-induced PI hydrolysis was completely insensitive to PTX on the other.21 Thus, P2-purinoceptor-mediated PI hydrolysis would be evoked primarily through PTX-insensitive G proteins, but a small part of the response might be mediated by PTX-sensitive G proteins. Alternatively, P2-purinoceptors might couple to PLC through single PTX-sensitive G proteins to which the receptors are very efficiently coupled, but we have not obtained any evidence that some receptor-mediated PLC activation is evoked entirely through PTX-sensitive G proteins in the myocytes. 21 Negative Feedback Control of the Dual Signal Transduction Systems by PKC PKC plays an important role in an immediate negative feedback control of intracellular signal transduction systems. 37 Figure 8 suggests that PKC inhibits P2-purinoceptor-mediated PI hydrolysis in the myocytes.32 PMA inhibited this response by .60% (Figure 8 ) but fluoroaluminate-induced PI hydrolysis by only 30%.21 This fact can probably be explained in terms of two sites of PKC action; one effect was at a post-G protein step and the other was probably at P2-purinoceptors, because PKC also attenuated the P2-purinoceptor-mediated inhibition of AC (see below). The negative feedback control by PKC was heterologous in nature, because PKC also inhibited 5-HT-induced PI hydrolysis in the myocytes.2'
On the other hand, Figure 9B suggests that PKC also negatively regulates P2-purinoceptor-mediated inhibition of the cAMP system32 and that PKC differentially regulates P2-and A,-purinoceptor-mediated responses. The latter observation supports the idea that ATPyS inhibits the cAMP system through receptors other than A1-purinoceptors ( Figure 5 and Table 3 ) and further suggests that the A1and P2-purinoceptor-mediated responses might be functionally different. In addition, because A1-purinoceptors and probably P2-purinoceptors also regulate AC through inhibitory G proteins (Figure 7) ,7 PKC might attenuate the P2-purinoceptor-mediated response by modulating P2-purinoceptors themselves.
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Circulation Research Vol 70, No 3 March 1992 Physiological Significance of the Second Messenger Cascades Coupled to P2-Purinoceptors in Cardiac Myocytes P2-purinoceptor-mediated PI hydrolysis has been proposed to mediate a positive inotropic effect.16 P2purinoceptor activation would also elicit depressant effects on cardiac contraction in the presence of ,3-adrenergic stimulation by inhibiting the cAMP system. The latter signaling pathway might also participate in direct inhibition of cardiac contraction by activating K' currents through PTX-sensitive G proteins,41 as reported in the bullfrog atrium.19 A P2-purinoceptor-mediated physiological response is probably composed of these elemental responses. However, the recent observation by Scamps et a142 seems to indicate that P2-purinoceptors do not couple to the cAMP system in rat papillary muscles. Thus, the efficiency of coupling of the receptors to each of the signal transduction systems or, in other words, the combination of the elemental responses might vary among animal species, developmental stages, and anatomic portions in the heart. If so, it would not be surprising that P2-purinoceptor-mediated responses are apparently so diverse. Of course, all of the responses could not be explained only in terms of the dual signaling pathways. It is necessary to recognize that the current experiments were conducted in isolated myocytes from fetal mice.
The physiological significance will ultimately depend on the ability to extrapolate the results from these experiments to more intact systems. However, our present observation that P2-purinoceptors are capable of coupling to plural signal transduction systems in cardiac myocytes would provide new insight into the complex cardiac responses to ATP.
